Glycogen storage disease (GSD) type 1a is caused by the deficiency Of
D-glucose-6-phosphatase (G6Pase), the key enzyme in glucose homeostasi
s. Despite both a high incidence and morbidity, the molecular mechanis
ms underlying this deficiency have eluded characterization. In the pre
sent study, the molecular and biochemical characterization of the huma
n G6Pase complementary DNA, its gene, and the expressed protein, which
is indistinguishable from human microsomal G6Pase, are reported. Seve
ral mutations in the G6Pase gene of affected individuals that complete
ly inactivate the enzyme have been identified. These results establish
the molecular basis of this disease and open the way for future gene
therapy.